Amanda Feilding

Guests Amanda Feilding, a pioneer in psychedelic research, Robin Carhart-Harris, creator of the 'entropic brain' theory, and renowned neuroscientist Christof Koch delve deep into consciousness and psychedelics. They discuss psilocybin's transformative effects and how it can aid in healing trauma. Christof shares his journey exploring 5-MeO-DMT, while Amanda reflects on shifting societal perceptions of psychedelics. Together, they challenge conventional neuroscience, revealing the profound implications these substances have on understanding consciousness.

Can neuroscience explain what happens to the brain on psychedelics? And even if we map the brain while it’s tripping, does that tell us why these experiences can be so transformative?  We’ll talk with some of the pioneers in psychedelic research — from Amanda Feilding’s boundary-busting work to Robin Carhart-Harris’ theory of the "entropic brain." Also, renowned neuroscientist Christof Koch goes down the rabbit hole on 5-MeO-DMT, also known as toad venom.   Original Air Date: July 15, 2023 Interviews In This Hour: Exploring consciousness on toad venom — The godmother of the European psychedelic revival — How therapeutic psilocybin could help heal long-buried trauma — Magic mushrooms and the 'entropic brain' Guests: Christof Koch, Amanda Feilding, David Nutt, Robin Carhart-Harris Never want to miss an episode? Subscribe to the podcast. Want to hear more from us, including extended interviews and favorites from the archive? Subscribe to our newsletter.

Amanda Feilding, the Founder of The Beckley Foundation, discusses psychedelic research, policy work, and the benefits of psychedelics in a mental health crisis. She advocates for evidence-based drug policies and highlights the neuroplasticity effects of LSD. Amanda shares her journey of scientific and policy work, emphasizing the distinction between psychedelics and other drugs. The podcast delves into cognitive enhancement with psychedelics, research challenges, and the evolving attitudes towards psychedelics globally.

Amanda Feilding, a trailblazing drug policy reformer and founder of the Beckley Foundation, dives deep into the transformative world of psychedelics. She shares fascinating insights from her early experiences with LSD, highlighting its role in understanding consciousness. The conversation explores the stigma surrounding psychedelics and their therapeutic potential, discussing groundbreaking research like psilocybin trials for depression. Amanda emphasizes the urgent need for intelligent drug policy reform and increased accessibility to psychedelic therapies in the face of a mental health crisis.

Neuroscientists discuss the transformative effects of psychedelics on the brain, from exploring consciousness on toad venom to therapeutic potential for treating depression. Pioneers like Amanda Feilding and Robin Carhart-Harris delve into the entropic brain theory and the neuroscience of psychedelics, including serotonin 2A receptors.